Sue Mei Jean, Yeap Swee Keong, Omar Abdul Rahman, Tan Sheau Wei
Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia.
Biomed Res Int. 2014;2014:653014. doi: 10.1155/2014/653014. Epub 2014 May 27.
Polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA) is an immunodetection method that can quantify PCR product directly after immobilization of biotinylated DNA on a microplate. This method, which detects nucleic acid instead of protein, is a much more sensitive method compared to conventional PCR method, with shorter analytical time and lower detection limit. Its high specificity and sensitivity, together with its semiquantitative ability, give it a huge potential to serve as a powerful detection tool in various industries such as medical, veterinary, and agricultural industries. With the recent advances in PCR-ELISA, it is envisaged that the assay is more widely recognized for its fast and sensitive detection limit which could improve overall diagnostic time and quality.
聚合酶链反应-酶联免疫吸附测定(PCR-ELISA)是一种免疫检测方法,可在将生物素化DNA固定在微孔板上后直接对PCR产物进行定量。该方法检测的是核酸而非蛋白质,与传统PCR方法相比,它是一种更为灵敏的方法,分析时间更短,检测限更低。其高特异性和灵敏度,以及半定量能力,使其在医疗、兽医和农业等各个行业中作为强大的检测工具具有巨大潜力。随着PCR-ELISA的最新进展,可以预见该检测方法因其快速且灵敏的检测限将得到更广泛认可,这有望缩短整体诊断时间并提高诊断质量。